Moderna, Inc. (MRNA) SEC Filings — 2025
13 SEC filings for Moderna, Inc. (MRNA) in 2025.
Filings
- Moderna Enters Material Definitive Agreement — 8-K · Nov 24, 2025
- Moderna, Inc. 8-K Filing — 8-K · Nov 20, 2025
- Moderna, Inc. 8-K Filing — 8-K · Nov 13, 2025
- Moderna's Q3 Loss Widens Amidst Revenue Dip, R&D Spend Cuts — 10-Q · Nov 6, 2025
- Moderna Files Proxy Materials — DEFA14A · Oct 20, 2025
- Moderna Seeks Shareholder Nod for Underwater Option Exchange — DEF 14A · Oct 15, 2025
- Moderna's Sales Plummet 62% Amid Post-Pandemic Vaccine Shift — 10-Q · Aug 1, 2025
- Moderna Inc. Files 8-K on Shareholder Votes — 8-K · May 5, 2025
- Moderna Files Q1 2025 10-Q — 10-Q · May 1, 2025
- Moderna Files 2025 Proxy Statement: Executive Compensation Details — DEF 14A · Mar 11, 2025
- Moderna Files 2024 10-K — 10-K · Feb 21, 2025
- Moderna Files 8-K on Financials — 8-K · Feb 14, 2025
- Moderna, Inc. Files 8-K on Financials — 8-K · Jan 13, 2025